Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v5-FR
Language English French
Date Updated 2021-01-14 2021-10-20
Drug Identification Number 02444992 02444992
Brand name BIO-ROSUVASTATIN BIO-ROSUVASTATIN
Common or Proper name ROSUVASTATIN ROSUVASTATIN
Company Name BIOMED PHARMA BIOMED PHARMA
Ingredients ROSUVASTATIN ROSUVASTATIN
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2021-01-13 2021-01-13
Estimated end date Unknown
Actual end date 2022-01-30
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments